Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Stem Cell Niche01:26

Stem Cell Niche

6.4K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.4K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter Regarding "Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation".

Angiology·2026
Same author

Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.

Diabetes & vascular disease research·2026
Same author

Life's Essential 8 and its role in cardiovascular health: evolution, evidence, and future directions.

Expert review of cardiovascular therapy·2026
Same author

Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study.

Diabetes & vascular disease research·2026
Same author

Current State of Computed Tomography Derived Fractional Flow Reserve (FFR-CT) and Its Diagnostic Advantages.

Clinical Medicine Insights. Cardiology·2026
Same author

Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation.

Angiology·2026

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.9K

Epigenetic changes in mesenchymal stem cells differentiation.

Ibrahim Mortada1, Rola Mortada1

  • 1Independent Consultant, Beirut, Lebanon.

European Journal of Medical Genetics
|October 29, 2017
PubMed
Summary

Epigenetic factors regulate stem cell differentiation. This review explores how epigenetic modifications influence mesenchymal stem cells (MSCs) for applications in regenerative medicine and experimental biology.

Keywords:
AdipogenesisChondrogenesisDifferentiationEpigeneticsOsteogenesis

More Related Videos

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
13:03

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

8.7K
Stencil Micropatterning of Human Pluripotent Stem Cells for Probing Spatial Organization of Differentiation Fates
08:07

Stencil Micropatterning of Human Pluripotent Stem Cells for Probing Spatial Organization of Differentiation Fates

Published on: June 17, 2016

9.0K

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.9K
Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
13:03

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

8.7K
Stencil Micropatterning of Human Pluripotent Stem Cells for Probing Spatial Organization of Differentiation Fates
08:07

Stencil Micropatterning of Human Pluripotent Stem Cells for Probing Spatial Organization of Differentiation Fates

Published on: June 17, 2016

9.0K

Area of Science:

  • Stem cell biology
  • Epigenetics
  • Regenerative medicine

Background:

  • Mesenchymal stem cells (MSCs) are crucial in regenerative medicine and experimental biology.
  • Their fate and differentiation are significantly influenced by epigenetic factors.
  • Understanding these mechanisms is key to advancing stem cell therapies.

Purpose of the Study:

  • To review the role of epigenetic changes in mesenchymal stem cells (MSCs) biology.
  • To highlight epigenetic impacts on MSC differentiation protocols (osteocytic, chondrocytic, adipocytic).
  • To discuss epigenetics in MSC transdifferentiation and its therapeutic potential.

Main Methods:

  • Literature review focusing on epigenetic mechanisms.
  • Investigation of chromatin remodeling, DNA methylation, and histone modifications.
  • Analysis of microRNA (miRNA) expression in MSC differentiation.

Main Results:

  • Epigenetic factors critically control MSC fate and differentiation pathways.
  • Specific epigenetic modifications (DNA methylation, histone changes, miRNAs) are key regulators.
  • Epigenetic modulation offers promising targets for stem cell research and therapies.

Conclusions:

  • Epigenetic modulation is a vital target for both basic and translational stem cell research.
  • Harnessing epigenetic mechanisms can enhance MSC-based therapeutic strategies.
  • Further research into epigenetic control of MSCs will drive innovation in regenerative medicine.